Sat. September 06, 2008
-
CNW Telbec (Communiqués de presse)
September 6, 2008
lung cancer Significant benefits in non-small-cell lung cancer from customising treatment (Embargoed until Saturday 13 September 2008, 12:45 CEST) Lung ...
KAUZ
September 6, 2008
In a trial of 20 terminally ill people some lung cancers were significantly reduced giving a handful of patients a few extra years. ...
Seattle Post Intelligencer
September 6, 2008
South Carolina Now
September 5, 2008
By Kelly Gillespie lung cancer can often times be prevented, and it's also one of the most difficult to detect early on. The Carolinas Hospital System in ...
Cancerpage.com
September 5, 2008
... the standard (every 3 week) regimen of paclitaxel and carboplatin for elderly patients with advanced nonsmall cell lung cancer (NSCLC), a study shows. ...
Science Daily (press release)
September 5, 2008
U.S. News & World Report
September 5, 2008
Kentucky had the highest
lung cancer rates for men and women (133.2 and 75.5, respectively), the third highest rate of laryngeal
cancers among men (9.7), ...
NJBIZ
September 5, 2008
(Nasdaq: CELG), a pharmaceutical company based in Summit, today announced that its lung cancer drug, "Amrubicin," has been granted "fast track" approval by ...
IndUS Business Journal
September 5, 2008
"The findings are critical to enhancing survival in lung cancer patients," Andaz, the director of thoracic oncology at South Nassau Communities Hospital on ...
CBS 4
September 5, 2008
Use of a minimally invasive technique called endoscopy to detect lung cancer may be more effective than more complicated and invasive standard procedures. ...
EurekAlert (press release)
September 5, 2008
Liverpool Daily Post
September 4, 2008
THE new chief executive of The Roy Castle lung cancer Foundation in Liverpool says she is looking forward to the challenge. Dr Rosemary Gillespie, 51, ...
GenomicsProteomics.com (press release)
September 4, 2008
The study, managed in partnership with Almac Diagnostics will utilise over 1500 non-small cell lung cancer (NSCLC) tumour samples from 15 research centres. ...
PR Web (press release)
September 3, 2008
Many home owners are shocked to find the home they live in contains
lung cancer,
asbestos and
mesothelioma risks posed by insulation on pipes, flooring and ...
Media Newswire (press release)
September 3, 2008
This vaccine trial, sponsored internationally by
GlaxoSmithKline, targets a protein called MAGE-A3, which is expressed in 35 percent of all
lung cancers and ...
Carolina Newswire (press release)
September 3, 2008
Raleigh, NC -
cancer is in the spotlight this week with the nationally televised "Stand up to Cancer" event, but
lung cancer survivors in our state, ...
Common Ground.ca
September 3, 2008
... early detection may be your best defence against
lung cancer. Researchers have recently demonstrated that routine CT screening reveals most
lung cancers ...
Pharmaceutical Business Review
September 3, 2008
Eligible patients include those with metastatic or recurrent non-small cell lung cancer (NSCLC) with K-RAS or EGFR-activated tumors, who have not received ...
Tampabay.com
September 3, 2008
By Lisa Greene, Times Staff Writer TAMPA - H. Lee Moffitt
cancer Center & Research Institute has received a $10.5-million federal grant to study
lung cancer ...
Telegraph.co.uk
September 3, 2008
By Roger Highfield,
science Editor Patients diagnosed with
lung cancer could see the odds of being successfully treated raised significantly by a new blood ...
ABC Action News
September 2, 2008
TAMPA, FL -- Moffitt
cancer Center is celebrating a grant totaling more than 10 million dollars towards
lung cancer research. This is Moffitts' first SPORE ...
Reuters
September 2, 2008
The
scientists analyzed the blood of both healthy people and patients with
lung cancer, colorectal
cancer and
diabetes, and found that those who were ill ...
Bizjournals.com
September 2, 2008
The grant will allow Moffitt to continue and enhance its efforts to contribute to the prevention and cure of lung cancer, Bepler said in the release. ...
TransWorldNews (press release)
September 2, 2008
Geraldine Kruemmelbein filed the lawsuit on August 20, claiming her husband's
lung cancer was caused by
asbestos exposure. Robert Kruemmelbein was diagnosed ...
MarketWatch
September 2, 2008
"Our entire team is extremely honored to be recognized by a panel of national lung cancer experts at the level of the NCI. ...
Cancerpage.com
September 2, 2008
NEW YORK SEPT 01, 2008 (Reuters Health) - A comparison of the effects of various forms of dietary vitamin E on lung cancer risk shows a strong independent ...
Boston Globe
September 1, 2008
Dr. Yolonda Colson, director of the Women's lung cancer Center at Brigham and Women's Hospital, is about to use the system in a surgical trial and shares ...
Irish Times
September 1, 2008
THE HEALTH Service Executive (HSE) was aware since September last year that a number of lung cancer patients in the northeast had been misdiagnosed, ...
Trading Markets (press release)
September 1, 2008
It is the SCC patients-accounting for about 30% of all lung cancer cases-and other "Avastin-ineligible" patients who are likely to be Erbitux's target ...
Malaysia Star
August 31, 2008
We need more public education that smoking does not cause all
lung cancers. Because of the stigma of smoking attached to
lung cancer, it receives less ...
AScribe (press release)
August 30, 2008
He is studying a protein called parathyroid hormone-related protein, produced by about two-thirds of lung cancers. This protein slows tumor growth in mice ...
Reuters
August 30, 2008
... that a trial of its
cancer drug Erbitux did not significantly improve overall survival in a trial of patients with the most common form of
lung cancer. ...
MarketWatch
August 29, 2008
"With less than one in five advanced-stage non-small cell lung cancer patients currently receiving biologic-based combination therapy in the first-line ...
Medi News Direct
August 29, 2008
Based on the study conducted among 143 individuals, including 49 non-small cell lung cancer patients, the researchers suggested that the test may aid in ...
MarketWatch
August 29, 2008
Seliciclib (CYC202 or R-roscovitine), a CDK (cyclin dependent kinase) inhibitor, is in Phase 2 for the treatment of
lung cancer and nasopharyngeal
cancer. ...
RedOrbit
August 29, 2008
Kidney and lung cancer patients reported the highest mean number of comorbid conditions. After relevant characteristics (Table 1), the number of comorbid ...
WBNG-TV
August 29, 2008
Since 2004, the Michael Connolly Endowment for lung cancer Research has raised more than a half million dollars. Action News reporter Gabe Osterhout tells ...
Ad-Hoc-News (Pressemitteilung)
August 28, 2008
Seliciclib (CYC202 or R-roscovitine), a CDK (cyclin dependent kinase) inhibitor, is in Phase 2 for the treatment of
lung cancer and nasopharyngeal
cancer. ...
Hamptons.com
August 28, 2008
Meanwhile, Laurie Carson, founder of the lung cancer Research Foundation and coordinator for the Third Annual Strides For Life Three-Mile Fun Run/Walk, ...
Madison County Record
August 28, 2008
By Kelly Holleran An
Illinois man recently diagnosed with
lung cancer has filed an
asbestos suit against 74 defendant
corporations, claiming the disease was ...
News Xrefs
[help]
Type or paste text (any length). Schema-Root.org cross-reference links will be embedded.
